Daily dose: Take one capsule daily, preferably in the morning, with 6-8 oz of water
That is a stall
Available at: Wegovy (semaglutide) injection 2.4 mg Prescribing Information
Heres how these medication options compare across both platforms: Disclaimer: Medication availability depends on a licensed clinicians evaluation and prescription
A person with high-sensitivity GLP1R variants may experience pronounced gastric slowing even at lower doses, raising contraceptive risk more than someone with lower-sensitivity variants at the same dose
Licensing (Marketing Authorisation): The MHRA has approved: Semaglutide (Wegovy) for adults with BMI 30 kg/m or BMI 27 kg/m with at least one weight-related comorbidity Liraglutide (Saxenda) with similar BMI criteria NHS Access (NICE Guidance): According to NICE guidance (TA664 for semaglutide), NHS-funded treatment is more restricted and typically available for adults with: BMI 35 kg/m with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease) For individuals from Black, Asian, and minority ethnic backgrounds, lower BMI thresholds may apply, recognising that these populations face increased metabolic risk at lower BMI levels
